Area of research
Nephrology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Chronic Kidney Disease and Diabetes, Renal Diseases and Glomerulopathies, Diabetes Treatment and Management, and Dialysis and Renal Disease Management.
Diabetes and its complications: molecular mechanisms, prevention and treatment.
Kidney Effects of Finerenone Added to Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease.
Serum total protein-to-albumin ratio and adverse clinical outcomes in patients with diabetes and chronic kidney disease: a comparative study of US and Chinese cohorts.
Artificial Intelligence in Diabetic Kidney Disease Research: Bibliometric Analysis From 2006 to 2024.
Prompt Engineering in Clinical Practice: Tutorial for Clinicians.
Ketogenic Diet, Serum Ketone Bodies and Risk of End-Stage Renal Disease in Patients With Diabetic Kidney Disease: A Multi-Cohort Study.
The prognostic impact of the Stress Hyperglycemia Ratio on End-Stage Renal Disease among patients with Diabetic Kidney Disease.
Case Report: TAFRO syndrome misdiagnosed as liver cirrhosis due to persistent abdominal distension
Mechanism of TGR5 in Ferroptosis of the Renal Tubular Epithelial Cells in Diabetes Mellitus and the Effect of Notoginsenoside Ft1.
Associations between depressive and anxiety symptoms and incident kidney failure in patients with diabetic nephropathy.
Effectiveness of Sodium-Glucose Transporter 2 Inhibitors and Semaglutide on Body Composition in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Real-World Cohort Study with Bioelectrical Impedance Analysis.
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
To target cellular senescence in diabetic kidney disease: the known and the unknown.
A Novel Integrated Pipeline for Site-Specific Quantification of N-glycosylation.
The associations of weekend warrior and other physical activity patterns with the risk of all-cause and cardiovascular disease mortality in people with diabetes mellitus and chronic kidney disease: from NHANES 2007-2020.
Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney disease.
Exploring the Potential of Claude 3 Opus in Renal Pathological Diagnosis: Performance Evaluation.
Impact of non-alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi-cohort longitudinal study.
DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/P66shc signaling pathway in diabetic kidney disease.
Common Needs of Patients with Diabetic Kidney Disease: Qualitative Analysis Based on Disease-Specific Social Media Platforms.
Clinical characteristics, outcomes and risk factors for mortality in hospitalized diabetes and chronic kidney disease patients after COVID-19 infection following widespread vaccination.
Exploring the Potential of Claude 3 Opus in Renal Pathological Diagnosis: Performance Evaluation (Preprint)
Postoperative pulmonary complications in older patients undergoing elective surgery with a supraglottic airway device or tracheal intubation
Associations of lactate dehydrogenase with risk of renal outcomes and cardiovascular mortality in individuals with diabetic kidney disease
MAGI2 ameliorates podocyte apoptosis of diabetic kidney disease through communication with TGF-β-Smad3/nephrin pathway.
Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study.
The association of plasma NT-proBNP level and progression of diabetic kidney disease.
Resting energy expenditure based on equation estimation can predict renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease.
Clinicopathological Characteristics and Risk Factors for Rapid eGFR Decline in Chinese Patients with Biopsy-Proven Obesity-Related Glomerulopathy.
Remnant cholesterol and the risk of diabetic nephropathy progression to end-stage kidney disease in patients with type 2 diabetes mellitus: A longitudinal cohort study